Status:
UNKNOWN
MOGGE PAR Scores for Prediction of Outcomes of PAS
Lead Sponsor:
Assiut University
Collaborating Sponsors:
Middle-East OBGYN Graduate Education Foundation
Conditions:
Placenta Accreta Spectrum
Eligibility:
FEMALE
18-45 years
Brief Summary
Placenta accreta spectrum (PAS) is a set of placentation disorders that are associated with trophoblastic invasion through the physiologic decidual-myometrial junction zone. PAS may be associated with...
Detailed Description
Incidence of PAS has significantly increased in concordance with rising trend of cesarean section delivery (CS) among contemporary population. Although cesarean hysterectomy, without trying to separa...
Eligibility Criteria
Inclusion
- Pregnant women with suspected Placenta Accreta Spectrum (PAS),confirmed by clinical and/ or histo-pathological findings.
- They must be planned to deliver in one of centers recruited in this study.
Exclusion
- Women who reject participation or whose diagnosis with PAS is eventually excluded based on clinical and/or histo-pathological findings.
Key Trial Info
Start Date :
October 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2021
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04525001
Start Date
October 1 2020
End Date
September 1 2021
Last Update
August 24 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.